Genome-Wide Diet-Gene Interaction Analyses for Risk of Colorectal Cancer

English version České info

High intake of red and processed meat and low intake of fruits, vegetables and fiber are associated with a higher risk of colorectal cancer. We investigate if the effect of these dietary factors on colorectal cancer risk is modified by common genetic variants across the genome (total of about 2.7 million genetic variants), also known as gene-diet interactions. We included over 9,000 colorectal cancer cases and 9,000 controls that were not diagnosed with colorectal cancer. Our results provide strong evidence for a gene-diet interaction and colorectal cancer risk between a genetic variant (rs4143094) on chromosome 10p14 near the gene GATA3 and processed meat consumption (p = 8.7E-09). This genetic locus may have interesting biological significance given its location in the genome. Our results suggest that genetic variants may interact with diet and in combination affect colorectal cancer risk, which may have important implications for personalized cancer care and provide novel insights into prevention strategies.

Vyšlo v časopise: Genome-Wide Diet-Gene Interaction Analyses for Risk of Colorectal Cancer. PLoS Genet 10(4): e32767. doi:10.1371/journal.pgen.1004228
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004228

Souhrn

Zdroje

1. SiegelR, NaishadhamD, JemalA (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10–29.

2. AlexanderDD, CushingCA (2011) Red meat and colorectal cancer: a critical summary of prospective epidemiologic studies. Obes Rev 12: e472–493.

3. AlexanderDD, MillerAJ, CushingCA, LoweKA (2010) Processed meat and colorectal cancer: a quantitative review of prospective epidemiologic studies. Eur J Cancer Prev 19: 328–341.

4. van DuijnhovenFJ, Bueno-De-MesquitaHB, FerrariP, JenabM, BoshuizenHC, et al. (2009) Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. The American journal of clinical nutrition 89: 1441–1452.

5. WuQJ, YangY, VogtmannE, WangJ, HanLH, et al. (2013) Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Annals of oncology : official journal of the European Society for Medical Oncology/ESMO 24: 1079–1087.

6. NomuraAM, HankinJH, HendersonBE, WilkensLR, MurphySP, et al. (2007) Dietary fiber and colorectal cancer risk: the multiethnic cohort study. Cancer causes & control : CCC 18: 753–764.

7. ParkY, HunterDJ, SpiegelmanD, BergkvistL, BerrinoF, et al. (2005) Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA : the journal of the American Medical Association 294: 2849–2857.

8. DahmCC, KeoghRH, SpencerEA, GreenwoodDC, KeyTJ, et al. (2010) Dietary fiber and colorectal cancer risk: a nested case-control study using food diaries. Journal of the National Cancer Institute 102: 614–626.

9. LinJ, ZhangSM, CookNR, RexrodeKM, LiuS, et al. (2005) Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States). Cancer causes & control : CCC 16: 225–233.

10. OllberdingNJ, WilkensLR, HendersonBE, KolonelLN, Le MarchandL (2012) Meat consumption, heterocyclic amines and colorectal cancer risk: the Multiethnic Cohort Study. International journal of cancer Journal international du cancer 131: E1125–1133.

11. LiuAY, SchererD, PooleE, PotterJD, CurtinK, et al. (2013) Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Molecular nutrition & food research 57: 721–734.

12. CotterchioM, BoucherBA, MannoM, GallingerS, OkeyAB, et al. (2008) Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17: 3098–3107.

13. FigueiredoJC, LewingerJP, SongC, CampbellPT, ContiDV, et al. (2011) Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20: 758–766.

14. HutterCM, Chang-ClaudeJ, SlatteryML, PflugeisenBM, LinY, et al. (2012) Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer research 72: 2036–2044.

15. HsuL, JiaoS, DaiJY, HutterC, PetersU, et al. (2012) Powerful cocktail methods for detecting genome-wide gene-environment interaction. Genetic epidemiology 36: 183–194.

16. GaudermanWJ, ZhangP, MorrisonJL, LewingerJP (2013) Finding novel genes by testing G×E interactions in a genome-wide association study. Genetic epidemiology 37: 603–613.

17. DaiJY, KooperbergC, LeblancM, PrenticeRL (2012) Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction. Biometrika 99: 929–944.

18. TenesaA, FarringtonSM, PrendergastJG, PorteousME, WalkerM, et al. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40: 631–637.

19. TomlinsonIP, WebbE, Carvajal-CarmonaL, BroderickP, HowarthK, et al. (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40: 623–630.

20. BroderickP, Carvajal-CarmonaL, PittmanAM, WebbE, HowarthK, et al. (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39: 1315–1317.

21. TomlinsonI, WebbE, Carvajal-CarmonaL, BroderickP, KempZ, et al. (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39: 984–988.

22. ZankeBW, GreenwoodCM, RangrejJ, KustraR, TenesaA, et al. (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39: 989–994.

23. HoulstonRS, WebbE, BroderickP, PittmanAM, Di BernardoMC, et al. (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 40: 1426–1435.

24. JiaWH, ZhangB, MatsuoK, ShinA, XiangYB, et al. (2012) Genome-wide association analyses in east Asians identify new susceptibility loci for colorectal cancer. Nature genetics 45: 191–196.

25. HosoyaT, MaillardI, EngelJD (2010) From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev 238: 110–125.

26. ChristophiGP, RongR, HoltzapplePG, MassaPT, LandasSK (2012) Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease. Inflammatory bowel diseases 18: 2342–2356.

27. GuptaRB, HarpazN, ItzkowitzS, HossainS, MatulaS, et al. (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133: 1099–1105 quiz 1340-1091.

28. ChouJ, ProvotS, WerbZ (2010) GATA3 in development and cancer differentiation: cells GATA have it!. Journal of cellular physiology 222: 42–49.

29. NguyenAH, TremblayM, HaighK, KoumakpayiIH, PaquetM, et al. (2013) Gata3 antagonizes cancer progression in Pten-deficient prostates. Human molecular genetics 22: 2400–2410.

30. ZhengR, BlobelGA (2010) GATA Transcription Factors and Cancer. Genes Cancer 1: 1178–1188.

31. RosenbloomKR, SloanCA, MalladiVS, DreszerTR, LearnedK, et al. (2013) ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic acids research 41: D56–63.

32. HedlundM, Padler-KaravaniV, VarkiNM, VarkiA (2008) Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proceedings of the National Academy of Sciences of the United States of America 105: 18936–18941.

33. BennettSN, CaporasoN, FitzpatrickAL, AgrawalA, BarnesK, et al. (2011) Phenotype harmonization and cross-study collaboration in GWAS consortia: the GENEVA experience. Genetic epidemiology 35: 159–173.

34. FortierI, DoironD, BurtonP, RainaP (2011) Invited commentary: consolidating data harmonization–how to obtain quality and applicability? American journal of epidemiology 174: 261–264 author reply 265-266.

35. SkolAD, ScottLJ, AbecasisGR, BoehnkeM (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nature genetics 38: 209–213.

36. PearceCL, RossingMA, LeeAW, NessRB, WebbPM, et al. (2013) Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22: 880–890.

37. PetersU, JiaoS, SchumacherFR, HutterCM, AragakiAK, et al. (2013) Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 144: 799–e724, 799-807, e724.

38. PriceAL, PattersonNJ, PlengeRM, WeinblattME, ShadickNA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.

39. NewcombPA, BaronJ, CotterchioM, GallingerS, GroveJ, et al. (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16: 2331–2343.

40. SlatteryML, PotterJ, CaanB, EdwardsS, CoatesA, et al. (1997) Energy balance and colon cancer–beyond physical activity. Cancer research 57: 75–80.

41. ChristenWG, GazianoJM, HennekensCH (2000) Design of Physicians' Health Study II–a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of epidemiology 10: 125–134.

42. ProrokPC, AndrioleGL, BresalierRS, BuysSS, ChiaD, et al. (2000) Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled clinical trials 21: 273S–309S.

43. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Controlled clinical trials 19: 61–109.

44. HoffmeisterM, RaumE, KrtschilA, Chang-ClaudeJ, BrennerH (2009) No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clinical pharmacology and therapeutics 86: 416–424.

45. BrennerH, Chang-ClaudeJ, SeilerCM, RickertA, HoffmeisterM (2011) Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Annals of internal medicine 154: 22–30.

46. KuryS, BuecherB, Robiou-du-PontS, ScoulC, SebilleV, et al. (2007) Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16: 1460–1467.

47. ColditzGA, HankinsonSE (2005) The Nurses' Health Study: lifestyle and health among women. Nature reviews Cancer 5: 388–396.

48. GiovannucciE, RimmEB, StampferMJ, ColditzGA, AscherioA, et al. (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Annals of internal medicine 121: 241–246.

49. JiaoS, HsuL, HutterCM, PetersU (2011) The use of imputed values in the meta-analysis of genome-wide association studies. Genetic epidemiology 35: 597–605.

50. WoolfB (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19: 251–253.

51. RischN, MerikangasK (1996) The future of genetic studies of complex human diseases. Science 273: 1516–1517.

52. A haplotype map of the human genome. Nature 437: 1299–1320.

53. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661–678.

54. HoggartCJ, ClarkTG, De IorioM, WhittakerJC, BaldingDJ (2008) Genome-wide significance for dense SNP and resequencing data. Genetic epidemiology 32: 179–185.

55. Pe'erI, YelenskyR, AltshulerD, DalyMJ (2008) Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genetic epidemiology 32: 381–385.

56. DudbridgeF, GusnantoA (2008) Estimation of significance thresholds for genomewide association scans. Genetic epidemiology 32: 227–234.

57. MukherjeeB, ChatterjeeN (2008) Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics 64: 685–694.

58. KooperbergC, LeblancM (2008) Increasing the power of identifying gene×gene interactions in genome-wide association studies. Genetic epidemiology 32: 255–263.

59. MurcrayCE, LewingerJP, GaudermanWJ (2009) Gene-environment interaction in genome-wide association studies. Am J Epidemiol 169: 219–226.

60. RoederK, WassermanL (2009) Genome-Wide Significance Levels and Weighted Hypothesis Testing. Statistical science : a review journal of the Institute of Mathematical Statistics 24: 398–413.

61. Ionita-LazaI, McQueenMB, LairdNM, LangeC (2007) Genomewide weighted hypothesis testing in family-based association studies, with an application to a 100K scan. American journal of human genetics 81: 607–614.

62. PiegorschWW, WeinbergCR, TaylorJA (1994) Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Statistics in medicine 13: 153–162.

63. DaiJY, KooperbergC, LeblancM (submitted) On two-stage hypothesis testing procedures via asymptotically independent statistics. J R Stat Soc Series B Stat Methodol

64. (2010) R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria.